AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- Patients with obesity dropped a mean 28% of their body weight with a 12-mg dose of the investigational triple-receptor agonist retatrutide over 80 weeks in a phase III study, Eli Lilly announced. Nearly half had weight loss of...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- The FDA's vaccine advisors will meet Thursday to vote on whether an XFG monovalent vaccine should be preferred for COVID-19 shots for the 2026-2027 season. The Vaccines and Related Biological Products Advisory Committee (VRBPAC...
(MedPage Today) -- A program that offered self-collected human papillomavirus (HPV) tests -- either mailed to patients or offered in clinic -- boosted cervical cancer screening rates among those due or overdue for screening, an evaluation of...
(MedPage Today) -- An investigational gene therapy passed muster for reducing PCSK9 and LDL cholesterol levels, with reassuring safety, among patients with heterozygous familial hypercholesterolemia (HeFH) or premature coronary artery disease ...
(MedPage Today) -- The FDA granted de novo approval for a neuromodulation device to treat symptoms associated with post-traumatic stress disorder (PTSD), maker Neurovalens announced Tuesday. The wearable, non-invasive device -- dubbed Modius...
